Phase II, Malaria High-Risk Populations in Namibia
Condition: Malaria Interventions: Drug: Presumptive treatment with Artemether-lumefantrine (AL); Other: Enhanced vector control Sponsors: University of California, San Francisco; University of Namibia; Ministry of Health and Social Services, Namibia; University of Texas Southwestern Medical Center; University of Notre Dame; London School of Hygiene and Tropical Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials